Drugs Made In America Acquisition Corp. - Ordinary Shares (DMAA) is listed on NASDAQ in the Finance, Insurance & Real Estate sector. This page tracks real-time DMAA price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
Fundamentals — 10-Q Q1 2026
Revenue --
Net Income $2.0M
EPS --
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Drugs Made In America Acquisition LLC | 10% Owner | Buy | 30,000 | $0.00 | $0 | 2025 Feb 18 |
| Stockwell Lynn | CEO and Exe. Chair of Board | Buy | 30,000 | $0.00 | $0 | 2025 Feb 18 |
| Drugs Made In America Acquisition LLC | 10% Owner | Buy | 5,298,363 | $0.00 | $0 | 2025 Jan 29 |
| Stockwell Lynn | CEO and Executive COB | Buy | 5,298,363 | $0.00 | $0 | 2025 Jan 29 |
Other Bank Stocks
- JPM JP Morgan Chase & Co.
- BAC Bank of America Corporation
- WFC Wells Fargo & Company
- ZKP Lafayette Digital Acquisition Corp. I - Class A Ordinary Shares
- SAC Safeguard Acquisition Corp. Class A Ordinary Shares
- PAII Pyrophyte Acquisition Corp. II Class A Ordinary Shares
- LATA Galata Acquisition Corp. II - Class A Ordinary Shares
- GPAC General Purpose Acquisition Corp. - Class A Ordinary Shares
Take DMAA further
- Browse Bank Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put DMAA in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Drugs Made In America Acquisition Corp. - Ordinary Shares next reports.
Set alerts on DMAA
Get notified when Drugs Made In America Acquisition Corp. - Ordinary Shares hits your price targets or technical conditions are met.
Get Started Free